NicErase-SL: Began a pilot Phase III trial

DynaGen Inc. (DYGN), Cambridge, Mass. Product: NicErase-SL sublingual lobeline sulfate Indication: Smoking cessation Status: Began a pilot Phase III trial in 180 smokers, who will take the tablets or ...